content

FDA Nod Given To Wuxi STA Shanghai Facility After Inspection

WuXi AppTecโ€™s WuXi STA has said that its facility at Waigaoqiao near Shanghai has cleared its first FDA drug product pre-approval inspection. Notably, the...

ChargePoint Technology Acquires Terracon Corporation

ChargePoint Technology, the powder transfer specialist, has today announced the acquisition of Terracon Corporation a leader in the design, development, and manufacture of single-use...

In-Vitro Biology Capabilities Expanded By Piramal Pharma

Piramal Pharma Solutions has confirmed that it has put in a multi-million dollar investment to create a top-notch screening facility that will elevate the...

CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity

CPhI Worldwide releases its beginning of year pharma market predictions for 2022 combining research from over 350 pharma executives and expert views from 10...

Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of COVID-19 Vaccine in 2022

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a revised supply agreement with the government of South Korea for...

Ascletis expands production of ritonavir oral tablets & oral direct-acting antiviral R&D pipeline to treat SARS-CoV-2 infection

Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2...

Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine

Amyris, Inc., a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market operating platform, and ImmunityBio, a clinical-stage immunotherapy company,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read